TANDEM DIABETES CARE, INC. — Net Income by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/685f784c-b65b-4361-8944-ebebad3596f8/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-204.7M | 2025-01-01 – 2025-12-31 | evidence 0001438133-26-000034 |
| FY 2024 | $-96.0M | 2024-01-01 – 2024-12-31 | evidence 0001438133-26-000034 |
| FY 2023 | $-222.6M | 2023-01-01 – 2023-12-31 | evidence 0001438133-26-000034 |
| FY 2022 | $-94.6M | 2022-01-01 – 2022-12-31 | evidence 0001438133-26-000034 |
| FY 2021 | $15.6M | 2021-01-01 – 2021-12-31 | evidence 0001438133-26-000034 |
| FY 2020 | $-34.4M | 2020-01-01 – 2020-12-31 | evidence 0001438133-21-000015 |
| FY 2019 | $-24.8M | 2019-01-01 – 2019-12-31 | evidence 0001438133-20-000014 |
| FY 2018 | $-122.6M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-004469 |
| FY 2017 | $-73.0M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-004141 |
| FY 2016 | $-83.4M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-003680 |
| FY 2015 | $-72.4M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-013192 |
| FY 2014 | $-79.5M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-000886 |
| FY 2013 | $-63.1M | 2013-01-01 – 2013-12-31 | evidence 0001564590-15-000886 |
| FY 2012 | $-33.0M | 2012-01-01 – 2012-12-31 | evidence 0001564590-15-000886 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
TANDEM DIABETES CARE, INC. — all facts · Revenue · Operating Income